166 related articles for article (PubMed ID: 2514343)
1. [Estrogen dependent plasminogen activator in breast cancer cells; experimental and clinical studies].
Yamashita J; Inada K; Matsuo S; Kawano I; Misumi A; Akagi M
Nihon Geka Gakkai Zasshi; 1989 Nov; 90(11):1932-8. PubMed ID: 2514343
[TBL] [Abstract][Full Text] [Related]
2. Estrogen-dependent plasminogen activator in 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors in vivo and in vitro.
Yamashita J; Horiuchi S; Shigaki N; Fujino N; Akagi M
Gan; 1984 Aug; 75(8):681-9. PubMed ID: 6436130
[TBL] [Abstract][Full Text] [Related]
3. Specific stimulation by estradiol of tissue-type plasminogen activator production in 7,12-dimethylbenz[a]anthracene-induced rat mammary tumor cells.
Yamashita J; Inada K; Yamashita S; Matsuo S; Nakashima Y; Ogawa M
Horm Metab Res; 1992 Dec; 24(12):565-9. PubMed ID: 1478614
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen activator as a functional marker for estrogen dependence in human breast cancer cells.
Yamashita J; Horiuchi S; Kimura M; Nishimura R; Akagi M
Jpn J Cancer Res; 1986 Feb; 77(2):177-81. PubMed ID: 3082829
[TBL] [Abstract][Full Text] [Related]
5. Hormonal modulation of plasminogen activator: an approach to prediction of human breast tumor responsiveness.
Mira-y-Lopez R; Ossowski L
Cancer Res; 1987 Jul; 47(13):3558-64. PubMed ID: 3107811
[TBL] [Abstract][Full Text] [Related]
6. Serum estrogens and estrogen responsiveness in 7,12-dimethylbenz[a]anthracene-induced mammary tumors as influenced by dietary fat.
Ip C; Ip MM
J Natl Cancer Inst; 1981 Feb; 66(2):291-5. PubMed ID: 6779045
[TBL] [Abstract][Full Text] [Related]
7. Hormone control of total plasminogen activator activity is specific to malignant DMBA-induced rat mammary tumours.
Inada K; Yamashita J; Matsuo S; Nakashima Y; Yamashita S; Ogawa M
Br J Cancer; 1992 Apr; 65(4):578-82. PubMed ID: 1562466
[TBL] [Abstract][Full Text] [Related]
8. Laboratory models of breast cancer to aid the elucidation of antiestrogen action.
Jordan VC
J Lab Clin Med; 1987 Mar; 109(3):267-77. PubMed ID: 3102656
[TBL] [Abstract][Full Text] [Related]
9. Peroxidase activity as a marker for estrogenicity: studies in uterus and mammary tumors.
Levy J; Liel Y; Glick SM
Isr J Med Sci; 1981; 17(9-10):970-5. PubMed ID: 7309486
[TBL] [Abstract][Full Text] [Related]
10. Hormonal regulation of plasminogen activator and peroxidase activities in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors and the rat uterus.
Inada K; Yamashita J; Yoshimura T; Matsuo S; Nakashima Y; Yamashita S; Misumi A; Ogawa M
Jpn J Surg; 1991 Mar; 21(2):249-52. PubMed ID: 1646904
[TBL] [Abstract][Full Text] [Related]
11. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
Pasqualini JR; Chetrite GS
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
[TBL] [Abstract][Full Text] [Related]
12. Antagonism of development and growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors by the antiestrogen U 23,469 and effects on estrogen and progesterone receptors.
Tsai TL; Katzenellenbogen BS
Cancer Res; 1977 May; 37(5):1537-43. PubMed ID: 404032
[TBL] [Abstract][Full Text] [Related]
13. Prolactin and estrogen dependency of rat mammary cancers at early and late stages of development.
Bradley CJ; Kledzik GS; Meites J
Cancer Res; 1976 Feb; 36(2 Pt 1):319-24. PubMed ID: 816459
[TBL] [Abstract][Full Text] [Related]
14. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats.
Allred CD; Allred KF; Ju YH; Clausen LM; Doerge DR; Schantz SL; Korol DL; Wallig MA; Helferich WG
Carcinogenesis; 2004 Feb; 25(2):211-8. PubMed ID: 14578162
[TBL] [Abstract][Full Text] [Related]
15. Effects of serum and insulin on the sensitivity of the human breast cancer cell line MCF-7 to estrogen and antiestrogens.
Butler WB; Kelsey WH; Goran N
Cancer Res; 1981 Jan; 41(1):82-8. PubMed ID: 7004631
[TBL] [Abstract][Full Text] [Related]
16. Potent inhibitory effect of a new antiestrogen (RU 16117) on the growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.
Kelly PA; Asselin J; Caron MG; Labrie F; Raynaud JP
J Natl Cancer Inst; 1977 Mar; 58(3):623-8. PubMed ID: 402479
[TBL] [Abstract][Full Text] [Related]
17. Isolation and purification of rat mammary tumor peroxidase.
DeSombre ER; Lyttle CR
Cancer Res; 1978 Nov; 38(11 Pt 2):4086-90. PubMed ID: 100215
[TBL] [Abstract][Full Text] [Related]
18. Hypophysectomy and injections of high doses of estrogens inhibit the growth of ovary-independent rat mammary carcinomas.
Nomura S; Yoshida H; Kaneko Y
In Vivo; 1990; 4(2):121-5. PubMed ID: 1966585
[TBL] [Abstract][Full Text] [Related]
19. Effects of aromatase inhibitor 4-hydroxyandrostenedione and other compounds in the 7, 12-dimethylbenz(a)anthracene-induced breast carcinoma model.
Brodie AM; Garrett WM; Hendrickson JR; Tsai-Morris CH
Cancer Res; 1982 Aug; 42(8 Suppl):3360s-3364s. PubMed ID: 6805949
[TBL] [Abstract][Full Text] [Related]
20. Inverse relation between estrogen receptors and cyclic adenosine 3':5'-monophosphate-binding proteins in hormone-dependent mammary tumor regression due to dibutyryl cyclic adenosine 3':5'-monophosphate treatment or ovariectomy.
Bodwin JS; Clair T; Cho-Chung YS
Cancer Res; 1978 Oct; 38(10):3410-3. PubMed ID: 210938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
